RAF 抑制剂在具有野生型 BRAF 的细胞中对 RAF 模态和 ERK 信号进行交换
Poulikos I Poulikakos1, Chao Zhang, Gideon Bollag
1Program in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Nature
|February 25, 2010
概括
在BRAF突变瘤中,RAF抑制剂通过防止悖论激活来阻止ERK信号传递. 这种机制解释了它们的有效性,并预测了与MEK抑制剂相比更好的治疗指数.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 具有BRAF突变的瘤依赖RAF-MEK-ERK途径进行生长.
- 矛盾的是,RAF抑制剂在野生型BRAF细胞中增强了ERK信号,与突变BRAF细胞不同.
研究的目的:
- 阐明野生型BRAF细胞中RAF抑制剂对悖论性的ERK信号激活的机制基础.
- 了解RAF抑制剂在突变型与野生型BRAF环境中的差异效应.
主要方法:
- 利用化学遗传方法来研究RAF二分体的交换活化.
- 分析了ERK信号诱导对药物结合和RAS活性的依赖性.
主要成果:
- 药物介导的RAF二元体的交换激活会导致RAF抑制剂对矛盾的ERK激活.
- 诱导ERK信号需要直接与ATP结合部位和RAS活性结合.
- 在BRAF (V600E) 瘤中,最小的RAS激活导致RAF抑制剂抑制ERK信号传递.
结论:
- 由于最小的悖论激活,RAF抑制剂在BRAF突变瘤中有效.
- 与MEK抑制剂相比,RAF抑制剂可能具有更高的治疗指数和更强的抗瘤活性.
- 增加RAF表达或RAS活性可以促进BRAF突变瘤的耐药性.
相关概念视频
The Ras Gene
5.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
5.7K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways
4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Receptor Tyrosine Kinases
15.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K


